Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy
International Journal of Clinical and Laboratory Research · 1992
DOI: 10.1007/bf02591388 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Laboratory Research, 1992. Verfasst von J R Wunderlich und 9 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Experimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892.
Zitieren
APA
Wunderlich, J. R., Mezzanzanica, D., Garrido, M. A., Neblock, D. S., Daddona, P. E., Andrew, S. M., Zurawski, V. R., Canevari, S., Colnaghi, M. I., & Segal, D. M. (1992). Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy. International Journal of Clinical and Laboratory Research. https://doi.org/10.1007/bf02591388
Vancouver
Wunderlich JR, Mezzanzanica D, Garrido MA, Neblock DS, Daddona PE, Andrew SM, et al. Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy. International Journal of Clinical and Laboratory Research. 1992. doi:10.1007/bf02591388
BibTeX
@article{Wunderlich1992,
author = {Wunderlich, J R and Mezzanzanica, D and Garrido, M A and Neblock, D S and Daddona, P E and Andrew, S M and Zurawski, V R and Canevari, S and Colnaghi, M I and Segal, D M},
title = {Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy},
journal = {International Journal of Clinical and Laboratory Research},
year = {1992},
doi = {10.1007/bf02591388}
}
EUVIMED